Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Lineage-specific chromatin poising enforced by ETS-IRF composite elements determines the divergent interferon responses of plasmacytoid dendritic cells and epithelial cells.

bioRxiv : the preprint server for biology·2026
Same author

B cell αv integrin regulates tissue specialization and clonal expansion of lung germinal center and memory B cells after viral infection.

Science advances·2026
Same author

Type I Interferon-Driven Monocyte Dysregulation and MAS-associated CD8<sup>+</sup> T cells During Macrophage Activation Syndrome.

bioRxiv : the preprint server for biology·2026
Same author

Coincident epithelial signals restrain commensal-specific CD8αβ<sup>+</sup> T cells in the intestine.

bioRxiv : the preprint server for biology·2026
Same author

Serum proteomics reveals distinct phenotypic signatures to IL-6 blockade between two immunotherapies.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: Multi-omic profiling reveals age-related immune dynamics in healthy adults.

Nature·2026

関連する実験動画

Updated: Sep 10, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

スクリーニング 第1型糖尿病の予測と予防の教訓

Cate Speake1, Adam Lacy-Hulbert2, James Lord3

  • 1Center for Interventional Immunology, Benaroya Research Institute, Seattle, WA, United States.

Inflammatory bowel diseases
|August 25, 2025
PubMed
まとめ

1型糖尿病 (T1D) は,現在,自己抗体検出によって,数年前に症状を予測することができます. T1Dの進行を遅らせるためのFDAが承認した治療法があり,免疫媒介性疾患の管理において重要な進歩を示しています.

キーワード:
オートアンチボディ免疫療法T1Dのステージ翻訳研究1型糖尿病の予測と予防

さらに関連する動画

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.9K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.6K

関連する実験動画

Last Updated: Sep 10, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.9K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.6K

科学分野:

  • 免疫学
  • 内分泌学
  • 臨床研究

背景:

  • 1型糖尿病 (T1D) と他の免疫媒介疾患は,健康に重大な課題をもたらします.
  • 予測と予防の進歩は これらの状態の管理に不可欠です

研究 の 目的:

  • T1Dの予測と予防における大きな進歩を強調する.
  • これらの進歩がT1Dや他の免疫媒介疾患に及ぼす影響について議論する.

主な方法:

  • T1Dのリスクのある個人を,自己抗体検査で特定する.
  • T1Dの進行を遅らせる治療法の開発と承認
  • 何十年にもわたる多中心研究と 共同研究を活かして

主要な成果:

  • 2つ以上の自己抗体を持つ人は,臨床T1Dを発症する可能性が高い.
  • T1Dはステージ化され,複数の自己抗体が初期段階の病気を示しています.
  • FDAが承認した治療は T1Dの発症を遅らせます

結論:

  • 早期発見と介入によって T1Dの管理が 変化しています
  • これらの突破は 他の免疫媒介疾患の 類似の戦略に道を開きます
  • 研究を臨床実用化することは 進行中ですが 望ましいことです